Program Area
Global Health

Our Goal
Help the Institute for OneWorld Health (iOWH), a nonprofit pharmaceutical firm, bring an old antibiotic called paromomycin to market for a new use: curing visceral leishmaniasis. 

Our Progress in Brief
Thanks to the hard work of our grantee, we are likely to achieve this goal in 2006 (one year later than originally planned). This is a significant milestone for the foundation. If, as expected, paromomycin is approved by the Indian drug authorities, it will be the first drug the foundation has played an important role in bringing all the way to regulatory approval.

The goals for this work have now expanded. Once it became clear that iOWH was likely to succeed in bringing the drug to market, both the foundation and iOWH recognized that for real impact they needed to extend this work beyond regulatory approval to distribution. We are now supporting iOWH’s work to ensure that the drug will reach those who need it most—all the way to the village level. We are in the early stages of addressing this new goal.

Next: The Challenge

Information in this case study is accurate as of June 2006